Cloud-clone
SKU:PAC056Hu01
Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)
Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14)
Couldn't load pickup availability
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
Product No.
PAC056Hu01
Organism Species
Homo sapiens (Human)
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPC056Hu01-Recombinant Matrix Metalloproteinase 14 (MMP14)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
Mus musculus (Mouse), Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against MMP14. It has been selected for its ability to recognize MMP14 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Cancer Research | Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer Aacrjournals: Source |
| Anticancer Research | Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro Pubmed:25202075 |
| Endocrine | GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes PubMed: 25743265 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPC056Hu02 | Recombinant Matrix Metalloproteinase 14 (MMP14) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC056Hu01 | Recombinant Matrix Metalloproteinase 14 (MMP14) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC056Hu01 | Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) | WB; IHC; ICC; IP. |
| PAC056Hu02 | Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) | WB,IHC,ICC/IF |
| MAC056Hu22 | Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14) | WB; IHC; ICC; IP. |
| SEC056Hu | ELISA Kit for Matrix Metalloproteinase 14 (MMP14) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC056Hu | Magnetic Luminex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
